Detalhe da pesquisa
1.
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation.
Cancer
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809547
2.
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Blood
; 139(12): 1908-1919, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914826
3.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol
; 99(5): 836-843, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400519
4.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Am J Hematol
; 99(4): 562-569, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314663
5.
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
BMC Cancer
; 23(1): 1258, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124057
6.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Am J Hematol
; 98(5): 712-719, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734029
7.
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
Am J Hematol
; 98(9): 1383-1393, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334870
8.
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
Blood
; 135(6): 449-452, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826244
9.
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
Haematologica
; 107(4): 899-908, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951890
10.
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission.
Am J Hematol
; 97(11): E408-E411, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054774
11.
Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation.
Ann Diagn Pathol
; 56: 151860, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823075
12.
Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia.
Int J Mol Sci
; 23(15)2022 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955881
13.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471943
14.
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy.
Cancer
; 127(19): 3541-3551, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182597
15.
Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
Am J Hematol
; 96(8): 914-924, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901324
16.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
17.
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 26(8): 1439-1445, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438043
18.
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(1): 197-203, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518645
19.
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1077-1083, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786242
20.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062061